Author:
Alousi Amin,Wang Tao,Hemmer Michael T.,Spellman Stephen R.,Arora Mukta,Couriel Daniel R.,Pidala Joseph,Anderlini Paolo,Boyiadzis Michael,Bredeson Christopher N.,Cahn Jean-Yves,Cairo Mitchell S.,Gadalla Shahinaz M.,Hashmi Shahrukh K.,Gale Robert Peter,Kanda Junya,Kamble Rammurti T.,Kharfan-Dabaja Mohamed A.,Litzow Mark R.,Ringden Olle,Saad Ayman A.,Schultz Kirk R.,Verdonck Leo F.,Waller Edmund K.,Yared Jean A.,Holtan Shernan G.,Weisdorf Daniel J.
Funder
Public Health Service
National Cancer Institute (NCI), National Heart, Lung and Blood Institute
National Institute of Allergy and Infectious Diseases
NHLBI and NCI
Health Resources and Services Administration
Subject
Transplantation,Hematology
Reference25 articles.
1. Peripheral-blood stem cells versus bone marrow from unrelated donors;Anasetti;N Engl J Med,2012
2. Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial;Lee;JAMA Oncol,2016
3. Bolanos-Meade J, Koreth J, Reshef R. A multi-center phase II trial randomizing novel approaches for graft-versus-host disease prevention compared to contemporary controls (1203). Available at: https://clinicaltrials.gov/ct2/show/NCT02208037. Accessed June 1, 2018.
4. Use of composite endpoints in clinical trials;Sankoh;Stat Med,2014
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献